These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 29085358)
41. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300 [TBL] [Abstract][Full Text] [Related]
42. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595 [TBL] [Abstract][Full Text] [Related]
43. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681 [TBL] [Abstract][Full Text] [Related]
44. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656 [TBL] [Abstract][Full Text] [Related]
46. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348 [TBL] [Abstract][Full Text] [Related]
47. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737 [TBL] [Abstract][Full Text] [Related]
48. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors. Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038 [TBL] [Abstract][Full Text] [Related]
49. Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma. Ono T; Azuma K; Kawahara A; Sasada T; Hattori S; Sato F; Shin B; Chitose SI; Akiba J; Hirohito U Oncotarget; 2017 Nov; 8(54):92699-92714. PubMed ID: 29190949 [TBL] [Abstract][Full Text] [Related]
50. A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma. Iseas S; Golubicki M; Robbio J; Ruiz G; Guerra F; Mariani J; Salanova R; Cabanne A; Eleta M; Gonzalez JV; Basiletti J; Picconi MA; Masciangioli G; Carballido M; Roca E; Mendez G; Coraglio M; Abba MC Transl Oncol; 2021 Jun; 14(6):101084. PubMed ID: 33789221 [TBL] [Abstract][Full Text] [Related]
51. The effect of SMAD4 on the prognosis and immune response in hypopharyngeal carcinoma. Song J; Wu J; Ding J; Liang Y; Chen C; Liu Y Front Med (Lausanne); 2023; 10():1139203. PubMed ID: 37035326 [TBL] [Abstract][Full Text] [Related]
52. Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial. Noguti J; Chan AA; Bandera B; Brislawn CJ; Protic M; Sim MS; Jansson JK; Bilchik AJ; Lee DJ Oncotarget; 2018 May; 9(34):23564-23576. PubMed ID: 29805756 [TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer. Hoffmann A; Behrens HM; Heckl S; Krüger S; Becker T; Röcken C J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834537 [TBL] [Abstract][Full Text] [Related]
54. Leukocytosis in non hematological malignancies--a possible tumor-associated marker. Shoenfeld Y; Tal A; Berliner S; Pinkhas J J Cancer Res Clin Oncol; 1986; 111(1):54-8. PubMed ID: 3949851 [TBL] [Abstract][Full Text] [Related]